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Letter to the editor
Postmoperative radiotherapy in NSCLC
Sir
We agtee completely with Bartelink and Jassem (1996), who point
out that, despite the conduct of several randomized controlled
trials (RCTs), the value ofpost-operative radiotherapy as an adju-
vant to surgery in non-small-cell lung cancer (NSCLC) remains
unproven. In common with many RCTs of cancer therapy, those
comparing surgery plus post-operative radiotherapy vs surgery
alone in NSCLC have been too small to detect moderate treatment
benefits with reliability.
The MRC Cancer Trials Office have therefore initiated a meta-
analysis to try to resolve this important clinical question. The
meta-analysis will be carried out on behalfofand published by all
collaborators. Updated individual patientdata(IPD) will be sought
from all relevant trials, provided that the method ofrandomization
precluded prior knowledge of the treatment assignment and
accrual took place between January 1965 and December 1995.
Both published and unpublished trials will be included. All
analyses will be based on intention to treat, data will be sought for
all randomized patients and no exclusions will be made.
To date, we have identified 10 RCTs (Israel et al, 1979; van
Houtte et al, 1980; Lung Cancer Study Group, 1986; Ricci et al,
1991; Mei et al, 1994; Debevec et al, 1996; Medical Research
Council Lung Cancer Working Party, 1996; EORTC 08861,
unpublished data; GETCB 05CB88, unpublished data; Lung
Cancer Study Group, unpublished data) that have compared post-
operative radiotherapy with surgery alone in NSCLC. In total,
these trials have recruited more than 2000 patients and the combi-
nation of the results of each of the trials may provide a reliable
answer to the question. Two early trials (Bangma 1972; Patterson
and Russell, 1962) will not be included. The meta-analysis was
launched in June 1996 and so far 80% of trialists have agreed to
take part in the project. Data from three trials, including that from
LUl1 (Medical Research Council Lung Cancer Working Party,
1996) are already in house. As with all meta-analyses, it is
extremely important that data from all relevant trials are included.
We would therefore bepleased to receive details ofany appropriate
trials, published orunpublished, that are notreferenced. This meta-
analysis is funded by the NHS R&D programme (NCPIU03).
L Stewart andSBurdett
MRC Cancer Trials Office,
5 Shaftesbury Road,
Cambridge CB2 2BW, UK
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